Rex Health Ventures Hero Image
STRATEGIC INVESTMENT.
BREAKTHROUGH INNOVATION.

Rex Health Ventures enables groundbreaking work to advance the future of health

Rex Health Ventures Building

Rex Health Ventures (RHV) enables groundbreaking work by investing in and fostering companies and technologies that advance the future of health.

  • Entrepreneur-friendly strategic investor that speeds access to new healthcare products and services to improve patient care
  • Established by UNC REX Healthcare in 2012 as part of its commitment to innovation
  • Partners with emerging companies throughout North Carolina and the U.S.
  • Leverages the talent and subject matter experts across the UNC REX and UNC Health Care network
Learn More About Rex Health Ventures

Active Portfolio

Arrivo Bioventures Logo
Baebies Logo
Emergo Therapeutics logo
Leiters Logo
Phononic Logo
Pryon Logo
Learn More About Our Current Investments Portfolio

Portfolio Exits

Aerial BioPharma Logo
Awarepoint Logo
BardyDX Logo
BioStable Logo
Gauss Logo
KitCheck Logo
Phynd Logo
Target
Veran
Learn More About Our Prior Investments Portfolio

Portfolio Spotlight: Phononic

Phononic is revolutionizing cooling and heating with solid-state thermal management solutions. Named to CNBC’s 2016 Disruptor 50 list for its innovation within the cooling and heating industry, as well as CNBC’s Disruptor 50 list for both 2016 and 2017, Phononic provides solid-state semiconductor technology that can be applied to everything from refrigeration to fiber optics, removing the barriers of traditional approaches and ushering in a new era of cooling and heating.

UNC REX served as the first testing site for Phononic’s medical grade refrigerator, which will now be installed throughout the new NC Heart and Vascular hospital. Learn more in this video.

Learn More About Phononic

Meet the Rex Health Ventures Team

Anita Watkins Headshot

Anita Watkins

Managing Director

Natasha Bonett Delong

Portfolio Manager

Evan Bernath

Investment Associate

Meet the Entire Rex Health Ventures Team

Get the latest investment news from Rex Health Ventures:

Vergent Bioscience Secures $21.5 Million Series B Financing to Advance Clinical Development of Tumor-Targeted Fluorescent Imaging Agent VGT-309

Financing led by Orlando Health Ventures includes a prominent group of new and existing investorsFunding supports further development of VGT-309 in lung cancer and other solid tumorsFluorescent agent is designed to enhance tumor visualization during minimally invasive and robotic-assisted cancer surgery October 04, 2022 08:00 AM Eastern Daylight Time MINNEAPOLIS–(BUSINESS WIRE)–Vergent Bioscience, a clinical-stage biotechnology […]

Company News

Clean Cooling Comes of Age

Phononic is bringing a thermoelectric approach to refrigeration and cooling “One of the strongest appeals is the deflationary impact of our cold-chain solution as opposed to building massive [refrigeration] warehouses for perishable goods. … You can use our cold-chain solutions integrated into the vehicle to have that coldness or frozenness on demand, so in the […]

Company News

Kit Check Partners with Genixus™ to Introduce RFID-Tagged Propofol as the First Product Within the KinetiX™ Line of Ready-to-Administer Syringes

Syringes will support procedural efficiency and care delivery in acute & critical care settings. August 31, 2022 10:00 AM Eastern Daylight Time ALEXANDRIA, Va.–(BUSINESS WIRE)–Kit Check, the leading automation vendor in Medication Intelligence™, today announced that its proprietary Radio Frequency Identification (RFID) technology will be incorporated in the new KinetiX™ Propofol syringes being developed by Genixus™, […]

Company News
See All the News from Rex Health Ventures